Patrick G. Enright, Director of Zenas BioPharma ZBIO, has filed 13 purchases and 6 sales on the open market. Over the past 12 months that comes to a net purchase of $20.1M. The latest trade was on 06/15.

PE

PE

Patrick G. Enright

Director

Company

Zenas BioPharma ZBIO

First filing

23/02/08

Trades

56 trades

Buys / sales

13 / 6

12-month net buying

$20.1M

Last trade

06/15

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Rapid Micro BiosystemsRPID	Open-market sale	02/04	02/06	49,000 sh	$3.88	$190,120	−100.0%
VeradermicsMANE	Open-market buy	02/05	02/05	1,075,000 sh2 trades	$17.00avg.	$18,275,000	+109.9%
Rapid Micro BiosystemsRPID	Open-market sale	01/23–02/03	02/03	108,739 sh4 trades	$4.36avg.	$473,735.34	−68.9%
Vera TherapeuticsVERA	Open-market buy	25/12/11	25/12/15	5,882 sh	$42.50	$249,985	No record
Zenas BioPharmaZBIO	Open-market buy	25/10/09	25/10/14	117,255 sh2 trades	$19.19avg.	$2,250,026.5	No record
Vera TherapeuticsVERA	Open-market buy	25/06/23–25/06/24	25/06/25	250,000 sh4 trades	$21.11avg.	$5,277,598.36	+7.5%
BioAge LabsBIOA	Open-market buy	24/09/27	24/09/27	400,000 sh	$18.00	$7,200,000	+30.5%
Zenas BioPharmaZBIO	Open-market buy	24/09/16	24/09/16	440,000 sh	$17.00	$7,480,000	+131.5%
Lexeo TherapeuticsLXEO	Open-market buy	23/11/07	23/11/09	454,545 sh	$11.00	$4,999,995	+21.5%
Jazz PharmaceuticalsJAZZ	Open-market sale	23/08/14	23/08/15	1,241 sh	$138.16	$171,456.56	−5.6%
Vera TherapeuticsVERA	Open-market buy	23/02/06	23/02/08	1,714,285 sh	$7.00	$11,999,995	No record